variable or clinical variable (including CA 125) entered a logistic regression model to predict malignancy in difficult masses. A model could be constructed for difficult masses containing papillary projections, but this model performed no better than subjective evaluation of the ultrasound image. Sensitivity and specificity of subjective evaluation with regard to malignancy in the group of unclassifiable masses were 56% (14/25) and 77% (50/65) vs.
Abstract
Objective. To determine which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings, and to determine if the use of logistic regression models for calculation of individual risk of malignancy would improve the diagnostic accuracy in difficult tumors.
Material and methods.
In a prospective international European multi-center study involving nine centers, 1066 women with a pelvic mass judged to be of extrauterine origin underwent transvaginal ultrasound examination by an experienced ultrasound examiner before surgery. A standardized examination technique and predefined definitions of ultrasound characteristics were used. On the basis of subjective evaluation of ultrasound findings, the examiner classified each mass as being certainly benign, probably benign, unclassifiable, probably malignant, or certainly malignant. Even when the examiner found the mass unclassifiable (i.e., difficult mass), he or she was obliged to state whether the mass was more likely to be benign or malignant. Borderline tumors were classified as malignant.
Results. There were 90 (8%) unclassifiable masses. Multiple logistic regression analysis showed papillary projections, >10 locules in a cyst without solid components, low level echogenicity of cyst fluid, and moderate vascularization as assessed subjectively at color Doppler examination to be ultrasound variables independently associated with unclassifiable mass. Borderline malignant tumors (n=55) proved to be most difficult to assess with only 47% being correctly classified (i.e., classified as malignant), 29% being incorrectly classified (i.e., classified as benign), and 24% being unclassifiable vs. 89% of non-borderline tumors being correctly classified, 3% being incorrectly classified, and 8% being unclassifiable (P < 0.0001). Papillary cystadeno(fibr)omas, myomas and cases of struma ovarii were also more common among the unclassifiable masses than among the classifiable ones (5.6% vs. 1.1%, p = 0.008; 4.4% vs. 0.9%, p = 0.02; 4.4% vs. 0.2%, p = 0.0006). No ultrasound
Introduction
Using subjective evaluation of gray scale and Doppler ultrasound findings, an experienced ultrasound examiner using a good ultrasound system can correctly classify extrauterine pelvic masses as benign or malignant in most cases 1, 2 , and suggest a correct specific diagnosis (e.g., endometrioma, dermoid cyst, or hydrosalpinx) in many cases 3 . The reported sensitivity and specificity with regard to malignancy in the studies cited were 88% and 96% 1 , and 96% and 90% 2 , respectively, and the reported sensitivity and specificity with regard to endometrioma were 92% and 97%, with regard to dermoid cyst 90% and 98%, and with regard to hydrosalpinx 100% and 100% 3 . However, in a small proportion of cases even a very experienced ultrasound examiner will find it difficult to discriminate between benignity and malignancy 1 .
The aim of this study was to determine which extrauterine pelvic masses are difficult to correctly classify as benign or malignant when using subjective evaluation of ultrasound findings as the diagnostic method, and to determine if the use of a logistic regression model for calculation of individual risk of malignancy would improve diagnostic accuracy in 'difficult' masses. Data were submitted via the internet to a central database using a dedicated, secure data collection system developed for the study 5 .
Subjects and methods
Statistical analysis was carried out using the SAS System release 8.
Student´s t-test and
Mann-Whitney´s test were used to test the statistical significance of differences in continuous data; the Chi-squared test and Fisher´s exact test were used to test the statistical significance of differences in discrete data. We used logistic regression with stepwise selection of variables to determine which ultrasound variables were independently associated with unclassifiable mass and for building a model to predict malignancy in difficult masses. Twotailed P-values < 0.05 were considered statistically significant.
Results
A total of 1149 patients were recruited. Data from 83 patients (7%) were excluded (eight because of pregnancy, 31 because surgery was undertaken more than 120 days from the sonographic assessment, 42 because of incomplete submission of data, two because of disagreement between pathologists over the histological diagnosis). Data from 1066 patients (93%) were available for statistical analysis and model development.
Clinical information including CA 125 values for the women included are shown in Table   1 . Women with unclassifiable masses (n = 90, i.e., 8% of all masses; 95% CI 7 -10%) were older and of higher parity than those with classifiable masses (n = 976). Histological diagnoses are presented in Table 2 . Endometriomas and primary invasive malignancies Stage II-IV were less common among the unclassifiable masses than among the classifiable ones.
Borderline tumors, papillary cystadenomas and (cyst)adenofibromas, myomas, and struma ovarii were over-represented among the unclassifiable masses, these diagnoses being three to twenty times more common among the unclassifiable masses than among the others. Of the borderline tumors, 47% (26/55) were correctly classified (i.e., classified as malignant) by the ultrasound examiner, 29% (16/55) were incorrectly classified (i.e., classified as benign), and 24% (13/55) were unclassifiable. Of the non-borderline tumors 90% (906/1011) were correctly classified, 3% (28/1011) were incorrectly classified, and 8% (77/1011) were unclassifiable. This difference between borderline and non-borderline tumors was statistically significant (P <0.0001).
Ultrasound findings are shown in Table 3 . Multiple logistic regression analysis showed papillary projections, >10 locules in a cyst without solid components, low level echogenicity of cyst fluid, and color score 3 (indicating moderate vascularization Examples of unclassifiable masses are shown in Figure 1 .
In unclassifiable masses the sensitivity and specificity of subjective evaluation of ultrasound findings with regard to malignancy were 56% (14/25) and 77% (50/65), the positive and negative likelihood ratios being 2.43 and 0.57. For the classifiable masses the corresponding figures were 91% (220/241), 97% (712/735), 28.5 and 0.09 (P < 0.0001 for the difference in sensitivity and P < 0.0001 for the difference in specificity). Table 5 .
Discussion
Our multicenter study has shown that experienced ultrasound examiners using high-end ultrasound systems find slightly less than 10% of pelvic masses judged to be of adnexal origin difficult to classify as benign or malignant on the basis of gray scale and color Doppler ultrasound findings. Masses with papillary projections, multilocular cysts with > 10 locules, cyst with low level echogenicity of cyst fluid and masses moderately vascularized at color Doppler ultrasound examination seem to be more difficult to classify than other types of tumor. The histological diagnoses that present the greatest diagnostic difficulties are borderline tumors, struma ovarii, papillary (cyst)adeno(fibro)mas, and myomas. We found no logistic regression model that was useful to distinguish between benignity and malignancy in difficult masses. However, a logistic regression model built on unclassifiable masses with papillary projections suggested that the more papillary projections and the larger the papillary projections the greater the risk of malignancy including borderline malignancy.
It is a strength of our study that it is large and involves many centers. Therefore, our results are likely to be generalizable to other experienced ultrasound examiners using good ultrasound systems provided that they are exposed to a population similar to our study population. We believe that our sample of masses is fairly representative of the types of extrauterine pelvic mass currently considered appropriate to remove surgically.
It was an unexpected finding that myomas were common among difficult masses. This is likely to be explained by some of the myomas in this series not being ordinary myomas. They were all suspected to be an adnexal mass both clinically and at ultrasound examination, and their ultrasound morphology was unclear enough to justify surgical removal.
Masses with papillary projections, multilocular cysts with >10 locules, and masses with low level echogenicity of cyst fluid were clearly overrepresented among the difficult masses. This is not surprising, because we found that these ultrasound features are characteristic of borderline tumors, and borderline tumors were overrepresented among the difficult tumors.
Others, too, found papillary projections and multilocularity to be characteristic of borderline tumors 6, 7 .
It is important to be able to reliably discriminate between benign and malignant adnexal masses in order to be able to correctly evaluate the need for surgery and to choose appropriate time and mode of operation. We have shown in this study that an experienced ultrasound examiner using a good ultrasound system can be expected to be able to correctly discriminate between benign and malignant adnexal masses in > 90% of all cases. However, in approximately 10 % of cases even an experienced ultrasound examiner using a good ultrasound system is likely to fail to make a confident and correct diagnosis. Before we have found a method capable of distinguishing between benignity and malignancy in such difficult pelvic masses (these new methods might prove to be use of intravenous ultrasound contrast, or proteomic pattern recognition), we must accept that some women will need to undergo an unnecessary operation -or perhaps an unnecessarily extensive operation -because of our inability to reliably exclude malignancy before operation. 
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